Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT01870609
Title Placebo Controlled Study of VS-6063 in Subjects With Malignant Pleural Mesothelioma
Acronym COMMAND
Recruitment Terminated
Gender both
Phase Phase II
Variant Requirements No
Sponsors Verastem, Inc.
Indications
Therapies
Age Groups: adult
Covered Countries USA | SWE | POL | NZL | NOR | NLD | ITA | GBR | FRA | ESP | CAN | BEL | AUS


No variant requirements are available.